Open AccessThe Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers
Author(s) -
Robert Cockburn,
Paul N. Newton,
E. Kyeremateng Agyarko,
Dora Akunyili,
Nicholas J. White
Publication year - 2005
Publication title -
plos medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.847
H-Index - 228
eISSN - 1549-1676
pISSN - 1549-1277
DOI - 10.1371/journal.pmed.0020100
Subject(s) - counterfeit drugs , counterfeit , business , drug industry , internet privacy , environmental health , medicine , computer security , political science , microbiology and biotechnology , computer science , law , biology
The production of substandard and fake drugs is a vast and underreported problem, particularly affecting poorer countries. Cockburn and colleagues argue that the pharmaceutical industry and governments must both take action